-
公开(公告)号：US20210277113A1
公开(公告)日：2021-09-09
申请号：US17256508
申请日：2019-06-28
Applicant: Alector LLC
Inventor： Andrew Pincetic , Patricia Culp , Arnon Rosenthal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPβ1 polypeptide, e.g., a human SIRPβ1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
Patent Agency Ranking
公开(公告)号：US12227568B2
公开(公告)日：2025-02-18
申请号：US16972840
申请日：2019-06-07
Applicant: Alector LLC
Inventor： Patricia Culp , Seung-Joo Lee , Helen Lam , Wei-Hsien Ho , Arnon Rosenthal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号：US20240301071A1
公开(公告)日：2024-09-12
申请号：US18627754
申请日：2024-04-05
Applicant: Alector LLC
Inventor： Andrew Pincetic , Wei-Hsien Ho , Patricia Culp , Arnon Rosenthal
CPC classification number: C07K16/283 , C07K16/246 , C07K16/2818 , C07K16/2827 , C07K16/40 , C07K16/4283 , C12N15/85 , C07K2317/21 , C07K2317/24 , C07K2317/32 , C07K2317/55 , C07K2317/567 , C07K2317/622 , C07K2317/732 , C07K2317/75 , C07K2317/76 , C07K2317/92
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPA polypeptide, e.g., a mammalian SIRPA or human SIRPA, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号：US12060422B2
公开(公告)日：2024-08-13
申请号：US17256508
申请日：2019-06-28
Applicant: Alector LLC
Inventor： Andrew Pincetic , Patricia Culp , Arnon Rosenthal
CPC classification number: C07K16/2803 , A61P35/00 , A61K2039/505 , A61K2039/507 , C07K2317/31 , C07K2317/33 , C07K2317/75 , C07K2317/92
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPβ1 polypeptide, e.g., a human SIRPβ1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号：US11254743B2
公开(公告)日：2022-02-22
申请号：US16869315
申请日：2020-05-07
Applicant: ALECTOR LLC
Inventor： Patricia Culp , Helen Lam , Arnon Rosenthal , Seung-Joo Lee , Nels P. Nielson , Robert Pejchal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号：US20190040131A1
公开(公告)日：2019-02-07
申请号：US16054840
申请日：2018-08-03
Applicant: ALECTOR LLC
Inventor： Patricia Culp , Helen Lam , Arnon Rosenthal , Seung-Joo Lee , Nels P. Nielson , Robert Pejchal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
-
-
-
-
Search Results
16
records
(took 0.04 seconds)
